Document Detail

Low Prevalence of High-dose Methotrexate Nephropathy in Patients With Malignancy.
MedLine Citation:
PMID:  22388607     Owner:  NLM     Status:  In-Data-Review    
Introduction. Methotrexate is an antifolate medication frequently used in the treatment of malignant and nonmalignant diseases. The usage of high-dose methotrexate was limited to patients with osteosarcoma, Ewing sarcoma, lymphoma, and acute lymphoblastic leukemia. One of the major side effects of high-dose methotrexate is nephropathy. The aim of present study was to determine the renal side effects of high-dose methotrexate in patients with malignancies. Materials and Methods. In a study of 102 patients with osteosarcoma (n = 72), Ewing sarcoma (n = 15), and lymphoma (n = 15), treated with high-dose methotrexate, clinical and laboratory data including kidney function tests were recorded at baseline and during follow-up visits. The mean duration of follow-up was 6 months. Results. The mean age of the patients was 19.5 years (range, 5 to 80 years). The total courses of methotrexate therapy were 273 (median, 2.67 per patient). The mean creatinine level was 0.82 mg/dL. Of the 102 patients, 3 (2.9%) developed acute kidney injury with an at risk phase. Another patient (1.0%) developed acute kidney injury and its phase was injury according to the RIFLE criteria. None of the cases were failed and acute kidney injury was alleviated in all of the affected patients. Conclusions. Our data revealed a low prevalence of acute kidney injury with high-dose methotrexate therapy. In addition, these toxicities were limited to the first and second phases of the RIFLE classification, all of which resolved spontaneously.
Mohammad Ali Mashhadi; Mahmoud Ali Kaykhaei; Houshang Sanadgol
Related Documents :
22127487 - Clinico-pathological correlation in duplex system ectopic ureters and ureteroceles: can...
22437807 - Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk fa...
22677407 - Decreased aortic root elasticity-as a novel systemic manifestation of the pseudoexfolia...
22549107 - Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-e...
9042387 - Two pyridinium metabolites of haloperidol are present in the brain of patients at post-...
24619517 - Cardiac involvement in dutch patients with sarcoglycanopathy: a cross-sectional cohort ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Iranian journal of kidney diseases     Volume:  6     ISSN:  1735-8604     ISO Abbreviation:  Iran J Kidney Dis     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101316967     Medline TA:  Iran J Kidney Dis     Country:  Iran    
Other Details:
Languages:  eng     Pagination:  105-9     Citation Subset:  IM    
Division of Oncology and Hematology, Department of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of alcoholic extract of Nigella sativa on cisplatin-induced toxicity in rat.
Next Document:  Brain Hemodynamics in Patients With End-stage Renal Disease Between Hemodialysis Sessions.